Related Experiment Videos
Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice
Abstract:
In mice, running, clonic and tonic convulsions and lethality were assessed following transcorneal (electroshock) current or convulsant drugs, each administered alone and after cannabidiol (CBD) pretreatment. CBD prevented tonic convulsions caused by a convulsant current (CC) 99.99, and by the convulsant dose (CD) 99.99 values of gamma-aminobutyric acid (GABA) inhibitors, 3-mercaptoproprionic acid (3MPA), picrotoxin (PIC), isonicotinic acid hydrazine (INH), pentylenetetrazol (PTZ) and bicuculline (BIC). Rankorder potencies, based on the antitonic ED50 of CBD, were: 3MPA greater than PIC = current = PTZ = BIC. Further, CBD prevented 3MPA-induced lethality, but failed to prevent the occurrence of the other behavioral endpoints of the above treatments. CBD also failed to prevent convulsions and lethality caused by the CD 99.99 of strychnine, a glycine antagonist. The differential effects of CBD suggest that the cannabinoid acts to inhibit seizure spread in the CNS by an action on GABA, but not glycine, mechanisms.
Insights
Cannabidiol (CBD) effectively prevented tonic seizures and some lethality in mice by interacting with GABA mechanisms, but not glycine pathways. This suggests CBD may inhibit central nervous system seizure spread.
Area of Science:
- Neuroscience
- Pharmacology
- Cannabinoid Research
Background:
- Epilepsy and seizure disorders represent significant neurological challenges.
- Cannabidiol (CBD), a non-psychoactive cannabis compound, has shown potential therapeutic properties.
- Understanding the precise mechanisms of CBD's anticonvulsant effects is crucial for its clinical application.
Purpose of the Study:
- To investigate the anticonvulsant effects of cannabidiol (CBD) in a mouse model.
- To determine the specific neurotransmitter systems targeted by CBD's seizure-inhibiting actions.
- To evaluate CBD's efficacy against different types of seizures induced by various convulsant agents.
Main Methods:
- Mice were pretreated with cannabidiol (CBD) before administration of electroshock current or convulsant drugs.
- Seizure activity (running, clonic, tonic convulsions) and lethality were assessed.
- Drugs used included GABA inhibitors (3-mercaptopropionic acid, picrotoxin, etc.) and a glycine antagonist (strychnine).
Main Results:
- CBD significantly prevented tonic convulsions induced by electroshock and several gamma-aminobutyric acid (GABA) inhibitors.
- The potency of CBD's antitonic effect varied, with 3-mercaptopropionic acid being most sensitive.
- CBD did not prevent convulsions or lethality induced by strychnine, a glycine antagonist, indicating a selective mechanism.
Conclusions:
- Cannabidiol (CBD) exhibits anticonvulsant properties, primarily by acting on GABAergic neurotransmission.
- CBD appears to inhibit seizure spread within the central nervous system (CNS) via GABA mechanisms.
- CBD's lack of effect on glycine-mediated seizures suggests a specific inhibitory role, not a general anesthetic effect.